We are live on ! Find out more
SC

Scholtz & Company Portfolio holdings

AUM $195M
1-Year Est. Return 12.04%
This Fund
S&P 500
This Quarter Est. Return
-11.04%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$115M
AUM Growth
-$43.4M
Cap. Flow
-$26.2M
Cap. Flow %
-22.75%
Top 10 Hldgs %
52.11%
Holding
64
New
10
Increased
11
Reduced
18
Closed
19

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$4.99M
2
DG icon
Dollar General
DG
+$4.86M
3
ETSY icon
Etsy
ETSY
+$3.66M
4
BA icon
Boeing
BA
+$2.88M
5
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Consumer Discretionary 18.04%
3 Technology 17.03%
4 Communication Services 7.13%
5 Financials 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
51
Meta Platforms (Facebook)
META
$1.49T
-16,017
Closed -$2.63M
MLCO icon
52
Melco Resorts & Entertainment
MLCO
$2.21B
-83,585
Closed -$1.77M
MMM icon
53
3M
MMM
$92B
-1,196
Closed -$211K
MTZ icon
54
MasTec
MTZ
$23B
-44,480
Closed -$1.99M
PBPB
55
DELISTED
Potbelly
PBPB
-90,070
Closed -$1.11M
SPGI icon
56
S&P Global
SPGI
$124B
-22,782
Closed -$4.45M
STZ icon
57
Constellation Brands
STZ
$22.5B
-10,865
Closed -$2.34M
TDOC icon
58
Teladoc Health
TDOC
$1.66B
-35,735
Closed -$3.09M
XPO icon
59
XPO
XPO
$23.4B
-146,839
Closed -$5.8M
ZION icon
60
Zions Bancorporation
ZION
$10B
-33,300
Closed -$1.67M
GWPH
61
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-21,135
Closed -$3.65M
RTN
62
DELISTED
Raytheon Company
RTN
-16,022
Closed -$3.31M

Similar funds

Scholtz & Company's Q4 2018 Portfolio in Review

As of Q4 2018, Scholtz & Company held 64 positions worth $115M, down 27% from $158M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Scholtz & Company withdrew a net $26.2M in Q4 2018, closing 19 positions and reducing 18 holdings. Its most notable exit was XPO, an estimated $5.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Scholtz & Company opened a new position in Crown Castle worth $4.93M.

  • Scholtz & Company's largest Q4 2018 buy was Crown Castle: 45,410 shares worth $4.93M.
  • Scholtz & Company added most to Boeing in Q4 2018, an estimated $2.88M increase.
  • Scholtz & Company's biggest Q4 2018 reduction was Viper Energy, cutting an estimated $2.89M.
  • Scholtz & Company fully exited XPO in Q4 2018, selling an estimated $5.8M.
  • Scholtz & Company's ten largest holdings make up 52% of its $115M portfolio in Q4 2018.
  • Scholtz & Company opened 10 new positions and closed 19 in Q4 2018.
  • Scholtz & Company's portfolio value fell 27% quarter-over-quarter to $115M.

Based on Scholtz & Company's 13F filing for Q4 2018, filed 29 Jan 2019.